UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Osimertinib as adjuvant therapy in patients (pts) with stage IB–IIIA EGFR mutation positive (EGFRm) NSCLC after complete tumor resection: ADAURA

Journal of clinical oncology, 2020-06, Vol.38 (18_suppl), p.LBA5-LBA5

2020

Volltextzugriff (PDF)

A phase I study of ADXS-503 alone and in combination with pembrolizumab in subjects with metastatic squamous or non-squamous non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e21682-e21682

2020

Volltextzugriff (PDF)

A phase Ib/II study of niraparib plus temozolomide plus atezolizumab versus atezolizumab as maintenance therapy in extensive-stage small cell lung cancer (TRIO-US L-06)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.TPS9084-TPS9084

2020

Volltextzugriff (PDF)

The role of chemotherapy plus immune checkpoint inhibitors in oncogenic driven non-small cell lung cancer: A University of California Lung Cancer Consortium retrospective study

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.9059-9059

2021

Volltextzugriff (PDF)

Neratinib efficacy in a subgroup of patients with EGFR exon 18 - mutant non-small cell lung cancer (NSCLC) and central nervous system (CNS) involvement: Findings from the SUMMIT basket trial

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.9068-9068

2021

Volltextzugriff (PDF)

EGFR-mutation detection in VTX-1-enriched CTCs, ctDNA, and comparison to tumor in patients with non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e20525-e20525

2017

Volltextzugriff (PDF)

Impact of Bearing Clearance on Measured Stiffness and Damping Coefficients and Thermal Performance of a High-Stiffness Generation 3 Foil Journal Bearing

Journal of engineering for gas turbines and power, 2018-07, Vol.140 (7)

2018

Volltextzugriff (PDF)

c-Met expression and response to telisotuzumab vedotin (teliso-v) in patients with non-small cell lung cancer

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.9023-9023

2019

Volltextzugriff (PDF)

Safety and tolerability of MEDI0562 in combination with durvalumab or tremelimumab in patients with advanced solid tumors

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.3003-3003

2020

Volltextzugriff (PDF)

Personajes que se le olvidaron a Montalvo: La caracterización femenina en "Capítulos que se le olvidaron a Cervantes"

Hispania, 2011-12, Vol.94 (4), p.637-647

Wade, Jonathan

2011

Volltextzugriff (PDF)

Personajes que se le olvidaron a Montalvo: La caracterización femenina en Capítulos que se le olvidaron a Cervantes

Hispania, 2011-12, Vol.94 (4), p.637-647

Wade, Jonathan

2011

Volltextzugriff (PDF)

Circulating tumor DNA (ctDNA) mutations may predict treatment response in extensive-stage small cell lung cancer (ES-SCLC) treated with talazoparib and temozolomide (TMZ)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.8564-8564

2021

Volltextzugriff (PDF)

Phase I trial of in situ vaccination with autologous CCL21 -modified dendritic cells (CCL21-DC) combined with pembrolizumab for advanced NSCLC

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS9135-TPS9135

2021

Volltextzugriff (PDF)

Nivolumab (nivo) + nab -paclitaxel ( nab -P) + carboplatin (C) in patients (pts) with non-small cell lung cancer (NSCLC): Interim results from a multicenter phase I study

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.9095-9095

2017

Volltextzugriff (PDF)

Clinical implications of the T790M mutation in disease characteristics and treatment response in patients with EGFR-mutated NSCLC

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.9031-9031

2017

Volltextzugriff (PDF)

Tuning interfacial interactions for bottom‐up assembly of surface‐anchored metal‐organic frameworks to tailor film morphology and pattern surface features: Nanoscience: Special Issue Dedicated to Professor Paul S. Weiss

Aggregate (Hoboken), 2022-08, Vol.3 (4)

2022

Volltextzugriff (PDF)

Interim subgroup analysis for response by PD-L1 status of CLASSICAL-Lung, a phase Ib/II study of pepinemab (VX15/2503) in combination with avelumab in advanced NSCLC

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.3011-3011

2020

Volltextzugriff (PDF)

First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.9068-9068

2020

Volltextzugriff (PDF)

Durvalumab ± tremelimumab + platinum-etoposide in first-line extensive-stage SCLC (ES-SCLC): Updated results from the phase III CASPIAN study

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.9002-9002

2020

Volltextzugriff (PDF)

Interim results from a phase Ib/II study of pepinemab in combination with avelumab in advanced NSCLC patients following progression on prior systemic and/or anti-PDx therapies

Journal of clinical oncology, 2020-02, Vol.38 (5_suppl), p.75-75

2020

Volltextzugriff (PDF)

Implementation and dissemination of a shared mental model of palliative oncology

Journal of clinical oncology, 2019-11, Vol.37 (31_suppl), p.58-58

2019

Volltextzugriff (PDF)

Safety and antitumor activity of durvalumab monotherapy in patients with pretreated extensive disease small-cell lung cancer (ED-SCLC)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.8518-8518

2018

Volltextzugriff (PDF)

Flower, Metaphor, and Portugalidade: António de Sousa de Macedo and Mariana de Luna’s Complementary Use of Flores

Revista de Escritoras Ibéricas, 2020-12, Vol.8, p.79

Wade, Jonathan

2020

Volltextzugriff (PDF)

Preliminary results from CLASSICAL-Lung, a phase 1b/2 study of pepinemab (VX15/2503) in combination with avelumab in advanced NSCLC

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.2601-2601

2019

Volltextzugriff (PDF)

26 – 50 von 847

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(729)
Mit Volltextzugriff
(707)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(483)
Life Sciences & Biomedicine
(386)
Humans
(295)
Female
(149)
Male
(148)
Adult
(98)
Middle Aged
(91)
Aged
(73)
Biological And Medical Sciences
(62)
Animals
(53)
General & Internal Medicine
(50)
Physical Sciences
(46)
Medical Sciences
(44)
Neurosciences & Neurology
(43)
Science & Technology - Other Topics
(43)
Patients
(42)
Multidisciplinary Sciences
(41)
Technology
(41)
Treatment Outcome
(41)
Surgery
(40)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Osimertinib as adjuvant therapy in patients (pts) with stage IB–IIIA EGFR mutation positive (EGFRm) NSCLC after complete tumor resection: ADAURA

A phase I study of ADXS-503 alone and in combination with pembrolizumab in subjects with metastatic squamous or non-squamous non-small cell lung cancer (NSCLC)

A phase Ib/II study of niraparib plus temozolomide plus atezolizumab versus atezolizumab as maintenance therapy in extensive-stage small cell lung cancer (TRIO-US L-06)

The role of chemotherapy plus immune checkpoint inhibitors in oncogenic driven non-small cell lung cancer: A University of California Lung Cancer Consortium retrospective study

Neratinib efficacy in a subgroup of patients with EGFR exon 18 - mutant non-small cell lung cancer (NSCLC) and central nervous system (CNS) involvement: Findings from the SUMMIT basket trial

EGFR-mutation detection in VTX-1-enriched CTCs, ctDNA, and comparison to tumor in patients with non-small cell lung cancer (NSCLC)

Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial

Impact of Bearing Clearance on Measured Stiffness and Damping Coefficients and Thermal Performance of a High-Stiffness Generation 3 Foil Journal Bearing

c-Met expression and response to telisotuzumab vedotin (teliso-v) in patients with non-small cell lung cancer

Safety and tolerability of MEDI0562 in combination with durvalumab or tremelimumab in patients with advanced solid tumors

Personajes que se le olvidaron a Montalvo: La caracterización femenina en "Capítulos que se le olvidaron a Cervantes"

Personajes que se le olvidaron a Montalvo: La caracterización femenina en Capítulos que se le olvidaron a Cervantes

Circulating tumor DNA (ctDNA) mutations may predict treatment response in extensive-stage small cell lung cancer (ES-SCLC) treated with talazoparib and temozolomide (TMZ)

Phase I trial of in situ vaccination with autologous CCL21 -modified dendritic cells (CCL21-DC) combined with pembrolizumab for advanced NSCLC

Nivolumab (nivo) + nab -paclitaxel ( nab -P) + carboplatin (C) in patients (pts) with non-small cell lung cancer (NSCLC): Interim results from a multicenter phase I study

Clinical implications of the T790M mutation in disease characteristics and treatment response in patients with EGFR-mutated NSCLC

Tuning interfacial interactions for bottom‐up assembly of surface‐anchored metal‐organic frameworks to tailor film morphology and pattern surface features: Nanoscience: Special Issue Dedicated to Professor Paul S. Weiss

Interim subgroup analysis for response by PD-L1 status of CLASSICAL-Lung, a phase Ib/II study of pepinemab (VX15/2503) in combination with avelumab in advanced NSCLC

First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes

Durvalumab ± tremelimumab + platinum-etoposide in first-line extensive-stage SCLC (ES-SCLC): Updated results from the phase III CASPIAN study

Interim results from a phase Ib/II study of pepinemab in combination with avelumab in advanced NSCLC patients following progression on prior systemic and/or anti-PDx therapies

Implementation and dissemination of a shared mental model of palliative oncology

Safety and antitumor activity of durvalumab monotherapy in patients with pretreated extensive disease small-cell lung cancer (ED-SCLC)

Flower, Metaphor, and Portugalidade: António de Sousa de Macedo and Mariana de Luna’s Complementary Use of Flores

Preliminary results from CLASSICAL-Lung, a phase 1b/2 study of pepinemab (VX15/2503) in combination with avelumab in advanced NSCLC

Suchergebnisse filtern